Aging Is Associated with reduced prostacyclin-mediated dilation in the human forearm

Wayne T. Nicholson, Brianna Vaa, Christiane Hesse, John H. Eisenach, Michael Joseph Joyner

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Aging is associated with reduced endothelial function. There is indirect evidence for reduced prostacyclin (PGI 2)-mediated vasodilation with aging, but it is unknown whether this is because of reduced dilation to PGI 2 or altered production. In addition, the contribution of endothelial NO to PGI 2-mediated dilation is unknown. Using plethysmog-raphy to determine forearm blood flow, we studied the effect of PGI 2 in 10 older (61 to 73 years) and 10 younger (19 to 45 years) subjects using 3 escalating intra-arterial doses of PGI 2 (epoprostenol). PGI 2 was also administered after NO synthase inhibition with A G-monomethyl-L-arginine acetate. The percent of change in forearm vascular conductance (mean±SEM) from baseline after PGI 2 was significantly lower (P=0.002) in the aging individuals (52±11%, 164±23%, and 221±27% versus 115±20%, 249±19%, and 370±35%). In addition, the group-by-dose interaction was also significant (P=0.018). After NO synthase inhibition, the dose-response curve to PGI 2 was blunted in the young subjects but unchanged in the older subjects; the difference between the groups was no longer significant. Our data suggest that the reduced dilator effects of PGI 2 in older individuals are attributable to a reduction in the contribution of endothelial-derived NO versus alterations in the direct effects of PGI 2 on vascular smooth muscle.

Original languageEnglish (US)
Pages (from-to)973-978
Number of pages6
JournalHypertension
Volume53
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Epoprostenol
Forearm
Nitric Oxide Synthase
Dilatation
Vascular Smooth Muscle
Vasodilation
Blood Vessels
Arginine
Acetates

Keywords

  • Aging
  • Blood flow
  • NO
  • Prostaglandins

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Aging Is Associated with reduced prostacyclin-mediated dilation in the human forearm. / Nicholson, Wayne T.; Vaa, Brianna; Hesse, Christiane; Eisenach, John H.; Joyner, Michael Joseph.

In: Hypertension, Vol. 53, No. 6, 06.2009, p. 973-978.

Research output: Contribution to journalArticle

Nicholson, Wayne T. ; Vaa, Brianna ; Hesse, Christiane ; Eisenach, John H. ; Joyner, Michael Joseph. / Aging Is Associated with reduced prostacyclin-mediated dilation in the human forearm. In: Hypertension. 2009 ; Vol. 53, No. 6. pp. 973-978.
@article{44e12aef172e411789e64a32e2219cb6,
title = "Aging Is Associated with reduced prostacyclin-mediated dilation in the human forearm",
abstract = "Aging is associated with reduced endothelial function. There is indirect evidence for reduced prostacyclin (PGI 2)-mediated vasodilation with aging, but it is unknown whether this is because of reduced dilation to PGI 2 or altered production. In addition, the contribution of endothelial NO to PGI 2-mediated dilation is unknown. Using plethysmog-raphy to determine forearm blood flow, we studied the effect of PGI 2 in 10 older (61 to 73 years) and 10 younger (19 to 45 years) subjects using 3 escalating intra-arterial doses of PGI 2 (epoprostenol). PGI 2 was also administered after NO synthase inhibition with A G-monomethyl-L-arginine acetate. The percent of change in forearm vascular conductance (mean±SEM) from baseline after PGI 2 was significantly lower (P=0.002) in the aging individuals (52±11{\%}, 164±23{\%}, and 221±27{\%} versus 115±20{\%}, 249±19{\%}, and 370±35{\%}). In addition, the group-by-dose interaction was also significant (P=0.018). After NO synthase inhibition, the dose-response curve to PGI 2 was blunted in the young subjects but unchanged in the older subjects; the difference between the groups was no longer significant. Our data suggest that the reduced dilator effects of PGI 2 in older individuals are attributable to a reduction in the contribution of endothelial-derived NO versus alterations in the direct effects of PGI 2 on vascular smooth muscle.",
keywords = "Aging, Blood flow, NO, Prostaglandins",
author = "Nicholson, {Wayne T.} and Brianna Vaa and Christiane Hesse and Eisenach, {John H.} and Joyner, {Michael Joseph}",
year = "2009",
month = "6",
doi = "10.1161/HYPERTENSIONAHA.108.121483",
language = "English (US)",
volume = "53",
pages = "973--978",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Aging Is Associated with reduced prostacyclin-mediated dilation in the human forearm

AU - Nicholson, Wayne T.

AU - Vaa, Brianna

AU - Hesse, Christiane

AU - Eisenach, John H.

AU - Joyner, Michael Joseph

PY - 2009/6

Y1 - 2009/6

N2 - Aging is associated with reduced endothelial function. There is indirect evidence for reduced prostacyclin (PGI 2)-mediated vasodilation with aging, but it is unknown whether this is because of reduced dilation to PGI 2 or altered production. In addition, the contribution of endothelial NO to PGI 2-mediated dilation is unknown. Using plethysmog-raphy to determine forearm blood flow, we studied the effect of PGI 2 in 10 older (61 to 73 years) and 10 younger (19 to 45 years) subjects using 3 escalating intra-arterial doses of PGI 2 (epoprostenol). PGI 2 was also administered after NO synthase inhibition with A G-monomethyl-L-arginine acetate. The percent of change in forearm vascular conductance (mean±SEM) from baseline after PGI 2 was significantly lower (P=0.002) in the aging individuals (52±11%, 164±23%, and 221±27% versus 115±20%, 249±19%, and 370±35%). In addition, the group-by-dose interaction was also significant (P=0.018). After NO synthase inhibition, the dose-response curve to PGI 2 was blunted in the young subjects but unchanged in the older subjects; the difference between the groups was no longer significant. Our data suggest that the reduced dilator effects of PGI 2 in older individuals are attributable to a reduction in the contribution of endothelial-derived NO versus alterations in the direct effects of PGI 2 on vascular smooth muscle.

AB - Aging is associated with reduced endothelial function. There is indirect evidence for reduced prostacyclin (PGI 2)-mediated vasodilation with aging, but it is unknown whether this is because of reduced dilation to PGI 2 or altered production. In addition, the contribution of endothelial NO to PGI 2-mediated dilation is unknown. Using plethysmog-raphy to determine forearm blood flow, we studied the effect of PGI 2 in 10 older (61 to 73 years) and 10 younger (19 to 45 years) subjects using 3 escalating intra-arterial doses of PGI 2 (epoprostenol). PGI 2 was also administered after NO synthase inhibition with A G-monomethyl-L-arginine acetate. The percent of change in forearm vascular conductance (mean±SEM) from baseline after PGI 2 was significantly lower (P=0.002) in the aging individuals (52±11%, 164±23%, and 221±27% versus 115±20%, 249±19%, and 370±35%). In addition, the group-by-dose interaction was also significant (P=0.018). After NO synthase inhibition, the dose-response curve to PGI 2 was blunted in the young subjects but unchanged in the older subjects; the difference between the groups was no longer significant. Our data suggest that the reduced dilator effects of PGI 2 in older individuals are attributable to a reduction in the contribution of endothelial-derived NO versus alterations in the direct effects of PGI 2 on vascular smooth muscle.

KW - Aging

KW - Blood flow

KW - NO

KW - Prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=67049134326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049134326&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.108.121483

DO - 10.1161/HYPERTENSIONAHA.108.121483

M3 - Article

C2 - 19414649

AN - SCOPUS:67049134326

VL - 53

SP - 973

EP - 978

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -